Some positive signs of structural changes to costs. More...

Some positive signs of structural changes to costs. More opportunities to reduce costs with product development.

Highlights

• Operating and Investing cashflow of ($0.1m) vs pcp of negative ($4.7m);

• Positive operating cashflow of $1.9m vs pcp of negative ($2.9m);

• 4th consecutive quarter of positive operating cashflow;

• Q3 EBITDA2 of $2.5m with EBITDA margin of 33% up $3m v pcp;

• North American revenue exceeds $1.7m on YTD basis;

• FY23 YTD year revenue of $22.4m up 9% v pcp1;

• Quarterly Revenue of $7.5m;

• ARR of $28.5m up 4% v Q2FY23 and consistent v pcp;
  
  Full year Guidance has been revised down $29.5m - $31m ($32-$34)
  
  Overall - IMO signs of turning the corner but it will clearly be a slow recovery - dependent on keeping current large clients, new clients, continued debt support and product development.